Trial record 80 of 318 for:
colon cancer | ( Map: Canada )
Study to Determine the Efficacy of Regorafenib in Metastatic Colorectal Cancer Patients and to Discover Biomarkers
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01949194 |
|
Recruitment Status :
Active, not recruiting
First Posted : September 24, 2013
Last Update Posted : August 10, 2018
|
Sponsor:
Gerald Batist
Collaborators:
Bayer
Quebec Clinical Research Organization in Cancer
Information provided by (Responsible Party):
Gerald Batist, Jewish General Hospital
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Active, not recruiting |
|---|---|
| Estimated Primary Completion Date : | October 2018 |
| Estimated Study Completion Date : | December 2018 |